Abstract
Fifty patients of advanced squamous cell carcinoma of head and neck received infusions of cisplatin 50 mg and 5-FU 500 mg weekly for 4 wk. At the end of chemotherapy, complete remission was seen in 14, partial remission in 25, minor remission in 5, and no response in 6 patients.
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Squamous Cell / drug therapy*
-
Cisplatin / administration & dosage
-
Female
-
Fluorouracil / administration & dosage
-
Head and Neck Neoplasms / drug therapy*
-
Humans
-
Infusions, Intravenous
-
Male
-
Middle Aged